|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Docetaxel for gastric and esophageal carcinomas 显示文摘 | Ajani JA | 2002 | Oncology (Williston Park)2002，16，616： | 1 |
| 2 | Treatment of patients with upper gastrointestinal carcinomas 显示文摘 | Ajani JA | 1997 | Semin Oncot1997，24，619： | 1 |
| 3 | Chemotherapy for gastric carcinoma:new and old options显示文摘 | Ajani JA | 1998 | Oncology(Williston Park)1998，12，107： | 1 |
| 4 | Docetaxel for gastric and esophageal carcinomas显示文摘 | Ajani JA | 2002 | Oncology (Williston Park)2002，6，66： | 1 |
| 5 | Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group显示文摘 | Ajani JA Moiseyemko VM Tjnlandin S | 2007 | J Clin Oncol2007，25，22： | 1 |
| 6 | Evolving chemotherapy for advanced gastric cancer显示文摘 | Ajani JA | 2005 | Oncologist2005，10，13： | 1 |
| 7 | Everolimus for previous- ly treated advanced gastric eaneer:resuhs of the randomized, double-blind,phase Ⅲ GRANITE-1 study 显示文摘 | Ohtsu A Ajani JA Bai YX | | J Clin On- col0，31，31： | 1 |
| 8 | Multieenter phase III comparison of cisplatin/S-I with eisplatin/infusional fluoroura- eil in advanced gastric or gastroesophageal adenocarcinoma study:the FLAGS trial显示文摘 | Ajani JA Rodriguez W Bodoky G | 2010 | J Clin Oncol2010，28，9： | 1 |
| 9 | Review of docetaxel in the treatment of gastric cancer显示文摘 | Tetzlaff ED Cheng JD Ajani JA | 2008 | Ther Clin Risk Manag2008，4，5： | 1 |
| 10 | Phase Ⅱ multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma 显示文摘 | Ajani JA Fodor MB Tjulandin SA | 2005 | J Clin Oncol2005，23，24： | 1 |
| 11 | Phase Ⅱ multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated,advanced gastric,or gastroesophageal adenocarcinoma显示文摘 | Ajani JA Fodor MB Tjulandin SA | 2005 | J Clin Oncol2005，23，24： | 1 |
| 12 | phase Ⅱ multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated,advanced gastric,or gastroesophageal adenocarcinoma显示文摘 | Ajani JA Fodor MB Tjulandin SA | 2005 | Journal of Clinical Oncology:official journal of the American Society of Clinical Oncology2005，23，24： | 1 |
| 13 | Phase II trial of preopera- tive chemoradiation in patients with localized gastric adenocarci- noma ( RTOG 9904 ) : Quality of combined modality therapy and pathologic response 显示文摘 | Ajani JA Winter K Okawara GS et at | 2006 | J Clin Oncol2006，24，24： | 1 |
| 14 | Fluorouracil,mitomycin,and radiotherapy vs fluorouracil,cisplatin,and radiotherapy for carcinoma of the anal canal显示文摘 | Ajani JA Winter KA Gunderson LL | | 0，，： | 1 |
| 15 | Phase II treal of preopera- tive ehemoradiation in patients with localized gagtrie adenocarcino- ma( RTOG 9904) :quality of combined modality therapy and patho- logic response 显示文摘 | Ajani JA Kathryn W Okawara GS | 2006 | J Clin Oncol2006，24，24： | 1 |
| 16 | Evolving chemotherap for advanced gastric can- cer显示文摘 | Ajani JA | 2005 | The Oncologist2005，10，7： | 1 |
| 17 | Irinotecan plus cisplatin in advanced gastric or gastroesophageal junction carcinoma显示文摘 | Ajani JA Baker J Pisters PW | 2001 | Oncology (Huntingt)2001，15，35： | 1 |
| 18 | Multicencer phase Ⅱ trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma显示文摘 | Ajani JA Lee FC Singh DA | 2006 | J Clin Oncol2006，24，4： | 1 |
| 19 | Proactive nurse management guidelines for managing intensive chemotherapy regimens in patients with advanced gastric cancer显示文摘 | Baker J Ajani JA | 2008 | Eur J Oncol Nurs2008，12，3： | 1 |
| 20 | Evolving chemotherapy for advanced gastric cancer显示文摘 | Ajani JA | 2005 | Oncologist2005，10，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员